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Available online 14 March 2017Cell senescence is increasingly recognized as a major contributor to the loss of health and ﬁtness associated with
aging. Senescent cells accumulate dysfunctional mitochondria; oxidative phosphorylation efﬁciency is decreased
and reactive oxygen species production is increased. In this review we will discuss how the turnover of mito-
chondria (a term referred to as mitophagy) is perturbed in senescence contributing to mitochondrial accumula-
tion and Senescence-Associated Mitochondrial Dysfunction (SAMD). We will further explore the subsequent
cellular consequences; in particular SAMD appears to be necessary for at least part of the speciﬁc Senescence-As-
sociated Secretory Phenotype (SASP) and may be responsible for tissue-level metabolic dysfunction that is asso-
ciatedwith aging and obesity. Understanding the complex interplay between thesemajor senescence-associated
phenotypes will help to select and improve interventions that prolong healthy life in humans.
Search strategy and selection criteria: Data for this review were identiﬁed by searches of MEDLINE, PubMed, and
references from relevant articles using the search terms “mitochondria AND senescence”, “(autophagy OR
mitophagy) AND senescence”, “mitophagyAND aging” and related terms. Additionally, searcheswere performed
based on investigator names. Abstracts and reports from meetings were excluded. Articles published in English
between 1995 and 2017 were included. Articles were selected according to their relevance to the topic as per-
ceived by the authors.versity Ag
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Senescent cells accumulate with age in a wide range of tissues. Fre-
quencies in excess of 5%, and sometimes as much as 20% and more,
have been reported in tissues from old animals both with high (whiteeing Biology Centre,
n Tyne NE4 5PL, UK.
an open access article undblood cells (Akbar et al., 2016); crypt enterocytes (Jurk et al., 2014;
Wang et al., 2009)) and low (dermal ﬁbroblasts (Dimri et al., 1995), he-
patocytes (Jurk et al., 2014; Wang et al., 2009), fat progenitors (Schafer
et al., 2016), osteocytes (Farr et al., 2016)) proliferation rates as well as
in postmitotic tissues (neurons (Jurk et al., 2012)). The rate of accumu-
lation of senescent cells in liver and intestinal crypts predicts median
and maximum lifespan of mice in cohorts with widely different aging
rates (e.g. late generation TERC−/− vs wt and dietary restricted
C57Bl/6) (Jurk et al., 2014). More importantly, interventions thater the CC BY license (http://creativecommons.org/licenses/by/4.0/).
8 V.I. Korolchuk et al. / EBioMedicine 21 (2017) 7–13selectively ablate senescent cells by genetic and/or pharmacologic
means may improve healthspan and lifespan in mice (Baker et al.,
2016; Demaria et al., 2017; Xu et al., 2015).
Mechanistically, the age-promoting effects of senescence are associ-
atedwith the restriction of regenerative capacity of stem andprogenitor
cells (Choudhury et al., 2007; Jurk et al., 2014) aswell as the secretion of
bioactivemolecules (the so-called SASP (Coppe et al., 2008)), speciﬁcal-
ly pro-inﬂammatory and matrix-modifying peptides. Pro-aging effects
of senescent cells are aggravated by SASP and, possibly, other paracrine
mediators which can propagate senescence from cell to cell as a by-
stander effect (Nelson et al., 2012). In recent years, evidence has been
mounting that senescent cells impact on their environment via yet an-
other principal pathway: mitochondrial dysfunction.
Alongwith cell senescence,mitochondrial dysfunction is another es-
sential ‘hallmark of aging’ (Lopez-Otin et al., 2013), and the two have
been independently identiﬁed as important drivers of aging (Finkel,
2015). Importantly, they are closely interlinked:mitochondrial dysfunc-
tion drives and maintains cell senescence (Correia-Melo et al., 2016;
Passos et al., 2007;Wiley et al., 2016),while at the same time cell senes-
cence, speciﬁcally persistent DNA damage response signalling, directly
contributes to Senescence-Associated Mitochondrial Dysfunction
(SAMD) (Passos et al., 2010). Despite the close interdependent relation-
ship between senescence and SAMD, the true complexity of these inter-
actions and their role in aging remains to be elucidated. For example, it
is currently unclear how much of the mitochondrial dysfunction that
has been observed at tissue level during aging is actually associated
with senescence at a cellular level. Furthermore, despite its central con-
tribution to the senescent phenotype (Correia-Melo et al., 2016), it is
not clear how mitochondria become dysfunctional in senescence. Im-
portantly, an understanding of the potential consequences of SAMD in
the context of tissue aging is only beginning to emerge. In this review,
we will explore the following hypotheses:
1. Senescence results in dysregulatedmitophagy that drives SAMD; and
2. SAMD is a signiﬁcant cause of (accelerated) aging.
We conclude thatmitophagy, SAMD and SASP are tightly interlinked
in cell senescence by a network of inter-related feedback signalling
pathways and that SAMD may be an essential cause of metabolic dys-
function in aging.
2. Dysfunctional mitochondria accumulate in senescent cells
It is well established that not only cell size but also mitochondrial
mass increases signiﬁcantly in senescent cells (Table 1). Kinetic studies
in stress-induced senescence showed that the increase inmitochondrial
mass is a fast but not immediate process, occurring with a delay of 2–
3 days after the peak in DNA damage but before a robust SASP is
established (Passos et al., 2010). As with most other senescence pheno-
types, mitochondrial accumulation has preferentially been studied in ﬁ-
broblasts, but occurs also in senescent epithelial cells (Hara et al., 2013),
hepatocytes (Correia-Melo et al., 2016), enterocytes (Jurk et al., 2014)
or neurons that develop a senescence-like phenotype in response to
persistent DNA damage (Jurk et al., 2012). In oncogene-induced senes-
cence, the activity of the mitochondrial ‘gatekeeper’ protein pyruvate
dehydrogenase is increased by simultaneous suppression of the PDH-Table 1
Metabolic changes in senescence and aging.
Mitochondrial mass MPP or
RS Increased (Passos et al., 2007) Decreas
OIS Increased (Moiseeva et al., 2009) Decreas
SIS Increased (Passos et al., 2010; Tai et al., 2017) Decreas
Aging in vivo Different results depending on tissue and methodology Decreas
brain (C
skeletal
RS, Replicative senescence; OIS, Oncogene-induced senescence; SIS, Stress-induced senescenceinhibitory enzymepyruvate dehydrogenase kinase 1 (PDK1) and induc-
tion of the PDH-activating enzyme pyruvate dehydrogenase phospha-
tase 2 (PDP2). The resulting combined activation of PDH enhanced the
use of pyruvate in the tricarboxylic acid cycle, causing increased respira-
tion and redox stress (Kaplon et al., 2013). In senescent cells, the expres-
sion of ﬁssion mediators Drp1 and Fis1 (Mai et al., 2010) and
frequencies of both fusion and ﬁssion events (Dalle Pezze et al., 2014)
are reduced, resulting in enhanced connectivity of the mitochondrial
network.
In functional mitochondria, oxygen uptake, ATP production, mem-
brane potential and generation of ROS are tightly regulated to maintain
the redox balance (Brand, 2016). While there is no simple correlation
between membrane potential and superoxide production by the elec-
tron transport chain, mitochondria that accumulate in senescence
often show a decreased membrane potential and at the same time pro-
duce increased levels of ROS (Table 1), suggesting dysfunctionality. In
accordance with this notion, the capacity of senescent cells to regulate
[Ca2+]i is decreased and a retrograde response is initiated (Passos et
al., 2007). In mitochondria from senescent cells, the Respiratory Control
Ratio (RCR, the ratio of oxygen uptake in state 3 (presence of ATP) to
state 4 (presence of oligomycin)), is much lower than in young cells
(Table 1), speciﬁcally if respiration is fuelled by complex I-linked sub-
strates. Together, these data show that the mitochondria that accumu-
late during cell senescence are dysfunctional. We propose the notion
of Senescence-Associated Mitochondrial Dysfunction (SAMD) for this
phenotype.
It should be noted that decreased activity of complex I, decreased
coupling and increased ROS production accompany the aging process
inmany tissues (Table 1), paralleling the increase in the frequency of se-
nescent cells in the same tissues (Jurk et al., 2014; Wang et al., 2009).
Mitochondrial dysfunction has a profound effect on cellular bioenerget-
ics (Fig. 1): First, increased mitochondrial mass is reﬂected by a signiﬁ-
cantly higher absolute oxygen consumption rate per cell in senescence
(Fig. 1A). Second, in senescent cells the fraction of ATP produced bymi-
tochondrial oxidative phosphorylation decreases, while relatively more
ATP is generated by glycolysis (Fig. 1B). Thus, both the increase in mito-
chondrial abundance and the shift towards a more glycolytic mode of
ATP production appear as compensatory responses to mitochondrial
dysfunction. Evidently, early occurrence of mitochondrial dysfunction
during the induction of cell senescence could set off a number of differ-
ent cellular responses and signalling pathways as well as reducing the
capacity to respond to peak energy demands.
In ionizing radiation (IR)-induced senescence, activation of p53
causes induction of the master regulator of mitochondrial biogenesis,
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
(PGC-1β) driving an increase in mitochondrial mass. This is not due to
a direct transactivation of PGC-1β, rather, p53 triggers murine double
minute 2 (MDM2)-mediated hypoxia inducible factor 1 α (HIF-1α)
degradation, leading to release of PGC-1β inhibition by HIF-1α
(Bartoletti-Stella et al., 2013). This is in accordance with data showing
HIF-1a as inducer ofmitophagy (Allen et al., 2013). In apparent contrast,
Sahin et al. (2011) described profound repression of both PGC-1α and
PGC-1β, associated with impaired mitochondrial biogenesis, in mice
null for either telomerase reverse transcriptase (TERT) or telomerase
RNA component (TERC) genes. Telomerase knock-out mice showrespiratory coupling ROS production
ed (Passos et al., 2010, 2007) Increased (Passos et al., 2007)
ed (Moiseeva et al., 2009) Increased (Moiseeva et al., 2009)
ed (Passos et al., 2010, 2007) Increased (Passos et al., 2010; Tai et al., 2017)
ed e.g. liver (Miwa et al., 2014);
occo et al., 2009);
muscle (Porter et al., 2015)
Increased e.g. liver (Miwa et al., 2014);
heart (Petrosillo et al., 2009); skeletal muscle
(Mansouri et al., 2006)
.
Fig. 1. Senescence drives changes in cell bioenergetics. Human MRC5 ﬁbroblasts were either fully proliferation competent (young) or replicatively senescent (sen). Cellular oxygen
consumption rates and extracellular acidiﬁcation rates were assayed in medium containing 5 mM glucose, 2 mM L-glutamate and 3% FBS using a Seahorse XF24 analyzer. A) Oxygen
consumption rates showing basal condition, and after sequential additions of the following drugs as indicated: oligomycin (to block ATP synthesis), the uncoupler FCCP (to stimulate
respiration) and Antimycin A (to block the electron transport chain at complex III). B) Relative glycolytic and mitochondrial ATP production rates were calculated using the data
generated in Fig. 1A as described (Mookerjee and Brand, 2015). Data are mean ± SD from 20 samples from 2 independent experiments.
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al., 2012, 2014; Passos et al., 2010) and mitochondrial dysfunction
(Spilsbury et al., 2015) in multiple tissues. A kinetic quantitative analy-
sis of the induction of stress-dependent senescence resolved this con-
tradiction (Dalle Pezze et al., 2014): PGC-1α (and presumably PGC-
1β) was upregulated only temporarily during the early DNA damage re-
sponse phase, but became down-regulated in established senescence.
This transient upregulation caused only a minor increase in mitochon-
drial mass, while the majority of mitochondrial accumulation occurred
later, when PGC-1β was already downregulated below control values.
With progression of senescence, mitochondria accumulated into a pro-
gressively more rigid network characterized by low fusion and ﬁssion
rates. Together with functional deterioration of accumulating mito-
chondria this suggested that a delay in autophagic degradation of defec-
tivemitochondria via a process calledmitophagy (see next chapter) is a
major contributor to mitochondria accumulation in stress-induced
senescence.
3. Autophagy is an essential mitochondrial quality control mecha-
nism implicated in senescence
3.1. Autophagy and cell senescence
Autophagy is a collective term for several cellular pathways facilitat-
ing degradation of intracellular components by lysosomal proteases.
Amongst autophagy pathways macroautophagy (hereafter for simplici-
ty called autophagy) is the best studied process (Fig. 2A). Autophagy be-
gins with the engulfment of surplus or damaged proteins and entire
organelles by double membraned vesicles called autophagosomes
which eventually fuse with lysosomes. The resulting hybrid organelle
is called autolysosome and allows degradation of autophagy substrates
and subsequent release of basic components such amino acids, lipids
and nucleotides back into the cytoplasm for biosynthetic processes
and energy generation. Autophagy activity is increased in conditions
of nutrient deprivation sensed via themechanistic Target of Rapamycin
Complex 1 (mTORC1) pathway and serves as a recycling process neces-
sary for cell survival during starvation. Importantly, autophagy is also a
quality control mechanism selectively scavenging potentially toxic cel-
lular components. Selective autophagy is classiﬁed on the basis of spe-
ciﬁc substrates with mitophagy being the most relevant to the topic of
this review. Autophagy has been implicated in the development of cel-
lular senescence. However, this relationship appears to be complex and
often contradictory (Fig. 2B). Thus, on one hand autophagy has been
suggested to act as a pro-senescence mechanism. Indeed, studies have
demonstrated that autophagy promotes the process of oncogene-induced senescence (OIS). Overexpression of the autophagy gene
ULK3 was found to enhance autophagy and stimulate senescence in-
duced by the RAS oncogene in human ﬁbroblasts (Young et al., 2009).
This effect of autophagy was suggested to be mediated by a specialized
intracellular structure called TOR-autophagy spatial coupling compart-
ment (TASCC) (Narita et al., 2011). TASCC was shown to allow simulta-
neous and compartmentalised generation of amino acids and other
metabolites by autophagy. Conversely, activation of themTORC1 signal-
ling pathway, a negative regulator of TASCC, promoted increased pro-
duction of SASP factors thus facilitating acquisition of senescence
phenotypes. Knockdown of the essential autophagy genes Atg5 and
Atg7was found to decrease SASP and bypass senescence (Narita et al.,
2011; Young et al., 2009). Likewise, overexpression of the inhibitors of
cyclin-dependent kinases p16(INK4A), p19(ARF) or p21(WAF1/CIP1)
induced not only senescence as expected but also autophagy
(Capparelli et al., 2012). Furthermore, autophagy induction by a proteo-
lytic Cyclin E fragment (p18-CycE) was shown to facilitate DNA-dam-
age-induced senescence (Singh et al., 2012).
At the same time, autophagy is well accepted as a protective, anti-
aging process (Rubinsztein et al., 2011) and, consistentwith this notion,
a number of reports strongly implicated autophagy in the prevention of
cellular senescence. In young, proliferating cells, inhibition of autophagy
leads to senescence, at least in part mediated by accumulation of reac-
tive oxygen species and activation of the tumour suppressor and senes-
cence inducer protein p53, suggesting that autophagy suppresses
senescence (Kang et al., 2011). Similarly, in models of mitochondria-
targeted damage or oxidative-stress induced senescence, autophagy
was shown to retard acquisition of senescence. Mitochondrial damage
increased expression of autophagy genes LC3B, ATG5 and ATG12 and en-
hancedmitophagy which postponed senescence and enhanced replica-
tive lifespan while peroxide treatment impaired autophagy ﬂux
resulting in senescence (Mai et al., 2012; Tai et al., 2017). Activation of
autophagy by inhibition of mTORC1 was shown to efﬁciently suppress
senescence phenotypes in a number of studies (Demidenko and
Blagosklonny, 2008; Correia-Melo et al., 2016; Tai et al., 2017). In con-
trast to the earlier reports suggesting an OIS-promoting role of autoph-
agy (Narita et al., 2011; Young et al., 2009) more recent reports have
shown that autophagy can act as a mechanism to bypass RAS-induced
senescence and facilitate tumour growth (Wang et al., 2012).
This contradictory role of autophagy in senescence may be ex-
plained, at least in part, by the complex nature of the autophagy process.
For example, increased numbers of autophagic vesicles could indicate
either increased autophagy or reduced ﬂux, e.g. due to defective traf-
ﬁcking, fusion with lysosomes or defective lysosomal compartment.
Moreover, different levels of autophagic activity can mediate different
Fig. 2. The potential role of mitophagy in senescence. A) Diagram showing the process of autophagy, exempliﬁed by mitophagy. Cytoplasmic contents including organelles such as
mitochondria are sequestered into double-membraned phagophore structures. This process can be selective and involves a number of receptor proteins; speciﬁcally for mitochondria
these include NDP52, optineurin and TAXBP1. These receptor proteins bind to poly-ubiquitinated proteins which, via binding to the phagophore-resident protein LC3, recruit their
cargo to the growing autophagosome. Ubiquitination of mitochondrial surface proteins can occur via stabilisation of PINK1 (PTEN-induced kinase 1) on the mitochondrial surface,
which recruits the E3 ubiquitin ligase, Parkin to mitochondrial membranes, thus promoting the ubiquitination and clearance of damaged mitochondria. The fully enclosed
autophagosome is trafﬁcked to and fuses with lysosomes. The contents of the subsequent autolysosome are degraded by lysosomal enzymes including hydrolases and proteases.
mTORC1 integrates intra- and extra-cellular signals and drives cell growth as well as inhibiting autophagy. B) In young proliferating cells, mTORC1 carefully balances anabolic vs
catabolic metabolism in response to the cellular environment. Both mTORC1 activity and autophagy are elevated in senescent cells while the speciﬁc process of mitophagy is reduced
(see text for more details). Autophagy has a complex relationship with senescence and can both promote and inhibit senescence and senescence-associated phenotypes. For example
in the context of OIS, autophagy induction can either promote or suppress acquisition of senescence while the speciﬁc role of mitophagy in OIS is currently less clear. Conversely,
lifespan-extending interventions such as caloric restriction and rapamycin induce autophagy and mitophagy and relieve senescence-associated phenotypes.
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induced senescence. Thus, high levels of autophagymay prevent OIS ac-
quisition, low levels may accompany it whilst more stringent inhibition
of autophagy may promote senescence (Wang et al., 2012). Moreover,
timing of autophagy inhibition is likely to be an essential factor for the
development of senescence. As described above, rendering autophagy
dysfunctional in young cells leads to senescence acquisitionwhilst in se-
nescent cells autophagy frequently appears to become upregulated,
which may be important for the establishment of senescence pheno-
types. Finally, a number of senescence regulators that either activate
or suppress senescence can be degraded by autophagy. Therefore, inhi-
bition of autophagy may differentially impact on the process of senes-
cence acquisition depending on the relative expression of these
autophagy substrates, type of inhibition etc. As an example, it has
been suggested that selective autophagy may suppress senescence
through the degradation of the pro-senescence factor GATA4 whilst se-
nescence may indeed be promoted by general autophagy through the
TASCC (Kang et al., 2015; Narita et al., 2011).
3.2. Mitophagy and cell senescence
Similar to other selective autophagy pathways, in mitophagy, speci-
ﬁcity is accomplished by a number of dedicated proteins, speciﬁcally the
PTEN-induced putative kinase PINK1 and Parkin, which ensure that mi-
tochondria with reduced membrane potential are targeted to nascent
autophagic vesicles by tagging them with polyubiquitin chains (Fig.2A). Ubiquitylatedmitochondria are recognized by a set of receptor pro-
teins including optineurin, NDP52 and TaxBP1 which in turn recruit au-
tophagic membranes engulﬁng and isolating mitochondria. Mitophagy
is important for themaintenance of cellular function and viability as ev-
idenced from familial age-related diseases caused bymutations in genes
encoding mitophagy components (Deas et al., 2011).
Interestingly, the regulation and functional role of mitophagy in cell
senescence appears to be at least in part independent of changes in gen-
eral autophagy (Fig. 2B). While general autophagy may become elevat-
ed or reduced depending on the model of senescence, mitophagy
activity is reduced in senescent cells in vitro and in vivo (Dalle Pezze
et al., 2014; Garcia-Prat et al., 2016). Several potential mechanisms
may be responsible for this impairment of mitophagy activity. It may
be a consequence of reduced basal or induced autophagic activity,
which in turn may result from changes in its upstream regulators like
mTOR. Indeed, in senescent cells activity of mTORC1 appears to be ele-
vated (Correia-Melo et al., 2016; Dalle Pezze et al., 2014; Demidenko
and Blagosklonny, 2008) and become unresponsive to starvation sig-
nals. Likewise, lysosomal overload will disrupt the terminal events of
substrate degradation in both general autophagy and mitophagy path-
ways (Evangelou et al., 2017). Indeed, despite an extensive expansion
of the lysosomal compartment during cell senescence, lysosomal activ-
ity is reduced and lysosomes accumulate undegraded material called
lipofuscin not only during aging but also in senescence (Sitte et al.,
2001). Lysosomal dysfunction may, at least in part, be driven by growth
arrest.
Fig. 3. The cell senescence signalling network. Signals downstream of the DDR cause
mitochondrial dysfunction via p38MAPK and TGFβ, SASP and chronic inﬂammation via
NF-κB and C/EBPβ and may directly or indirectly suppress autophagy and mitophagy.
SASP and mitochondrial dysfunction feedback to maintain and enhance DNA damage at
least partly via ROS generation. Many potential interactions within the network
(indicated by red arrows) are still insufﬁciently understood. See text for further details.
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independent of general autophagy. Cytoplasmic p53, which accumu-
lates in senescence, interacts with Parkin and prevents its translocation
to dysfunctional mitochondria, thus suppressing mitophagy and
stabilising senescence (Ahmad et al., 2015). Similarly, expression of
PINK1 is low in aging lungs, suppressing mitophagy and enhancing
the probability of senescence transition (Bueno et al., 2015). PINK1 de-
ﬁciency also suppresses the process of mitochondrial ﬁssion, which is
important for mitophagy by facilitating the separation of dysfunctional
portions from the mitochondrial network. Reduced dynamics and in-
creased fusion of the mitochondrial network in senescent cells has
been proposed to result in the failure to sequester defective components
ofmitochondrial network for degradation viamitophagy (Dalle Pezze et
al., 2014). As a result, “old” mitochondria avoid degradation while
newly synthesised isolatedmitochondria are turned over bymitophagy.
4. SAMD as a cause of senescence and aging
Data reviewed so far suggest that senescence is associated with dys-
regulated mitophagy and a subsequent accumulation of dysfunctional
mitochondria. This senescence-associated mitochondrial dysfunction
is a signiﬁcant trigger of multiple dimensions of the senescent pheno-
type. Dysfunctional mitochondria in senescent cells produce enhanced
levels of ROS which aggravate DNA damage and the DNA damage re-
sponse signalling pathway (DDR), contributing to the development
and stability of the senescent growth arrest (Passos et al., 2010). More-
over, dysfunctional mitochondria release multiple forms of “intracellu-
lar danger-associated molecular patterns” (DAMPs), especially ROS
and mtDNA fragments, that are recognized by NOD-like receptors
(NLR), especially NLRP3, triggering inﬂammasome assembly and activa-
tion of pro-inﬂammatory cytokines IL-1β and IL-18 (Salminen et al.,
2012). Enhanced autophagic clearance of mitochondria suppressed
NLRP3 activation (Nakahira et al., 2011; Zhou et al., 2011). This pathway
interacts positively with NF-κB signalling enhancing transcription of
many pro-inﬂammatory genes. Thus, mitophagy failure leading to
SAMDmay be responsible for the pro-inﬂammatory armof the SASP. In-
terestingly,mitochondrial dysfunction (induced bydepletion ofmtDNA,
mitochondrial sirtuins or by inhibition of the mitochondrial electron
transport chain) that did not cause elevated cytoplasmic ROS and did
not activate the DDR induced a senescent state that lacked the expres-
sion of the vast majority of the cytokines usually seem as part of the
SASP (Wiley et al., 2016). Moreover, speciﬁc removal of all mitochon-
dria in senescing human ﬁbroblasts by activation of the ubiquitin ligase
Parkin rescued the hyperproduction of ROS together with all other ex-
amined markers of the senescent phenotype (enlarged cell size, sen-
β-Gal production, CDKN1A (p21) and CDKN2A (p16) expression,
SASP) except growth arrest (Correia-Melo et al., 2016). The same sup-
pression of the senescent phenotype includingmajor SASP components
has been achieved by treatment of cells ormicewith themTOR inhibitor
and autophagy activator, rapamycin (Demidenko and Blagosklonny,
2008; Correia-Melo et al., 2016). Together, these data strongly implicate
SAMD as a major driver of the senescent phenotype, especially of the
SASP.
Importantly, the interconnections between SAMD, SASP and cell se-
nescence do not form a simple linear cause-effect relationship. There is
ample evidence for the existence ofmultiple positive feedback loops be-
tween the major components of the senescent phenotype (Fig. 3). Pos-
itive feedback loops between SASP factors and DDR (Acosta et al., 2008;
Kuilman et al., 2008) or between SAMD and DDR (Passos et al., 2010)
are well documented. It has also been shown that chronic activation of
NF-κB not only enhances the SASP but also aggravates ROS production
and the DDR in senescence (Jurk et al., 2014) possibly at least in part
via a ‘non-canonical’ function of NLRP3. There is also evidence for
intriguing interactions between SASP, SAMD and the extracellular
matrix (ECM) (Fig. 3): Senescent cells are known to negatively impact
their surrounding environment, including both bystander cells andcomposition and structure of the ECM via secretion of matrix metallo-
proteinases, especially MMP-1, and decreased expression of its endoge-
nous inhibitor TIMP-1 as part of the SASP, resulting in ECM degradation
with aging (Brennan et al., 2003). SAMDmay play an important role for
these degenerative changes, as they can be triggered by retrograde sig-
nalling in response to mtDNA mutations and electron transport chain
dysfunction (Krutmann and Schroeder, 2009; Wiley et al., 2016). ECM
collagenolysis autonomously inhibits further pro-collagen synthesis
and down-regulates hyaluronic acid synthase 2 (Rock et al., 2011), fur-
ther contributing to ECM degeneration. Hyaluronic acid is a linear poly-
saccharide with pro- or anti-proliferative properties depending on its
molecular weight; the extremely high molecular weight hyaluronic
acid produced by naked mole rats is a major determinant of their re-
markable tumour resistance because of its strong anti-proliferative ef-
fect (Tian et al., 2013). It is thus probable that ECM remodelling by
senescent cells feeds back into aggravation of the senescent phenotype
andmitochondrial dysfunction in thematrix-embedded cells. Together,
these data show that mitochondrial dysfunction is both a cause and a
consequence of senescence. Thus, mitochondrial turnover and especial-
ly mitophagy might be the central regulator of cell senescence (Fig. 3).
5. Outstanding questions
Mitochondrial dysfunction is well accepted as a driver of tissue and
organism aging with potential to modulate aging either positively or
negatively depending on a set of insufﬁciently understood conditions
(Wang and Hekimi, 2015). An important question is to what extent
aging-associated mitochondrial dysfunction and cell senescence/
SAMD are interrelated. Does aging-related mitochondrial dysfunction
cause senescence in vivo or vice versa? Is mitochondrial dysfunction
in aging actually a mosaic phenomenon, occurring preferentially or ex-
clusively in the senescent cells? Given the high prevalence of senescent
cells inmany tissues (see above), this appears highly possible. Emerging
data suggest that it is SAMD rather more than general loss of mitochon-
drial function in aging that reduces homeostatic capability, causing
compromised responses to peak energy demand and driving metabolic
insufﬁciency in aging. For instance, we have found that SAMD in hepa-
tocytes (and other cell types) includes a compromised capacity to me-
tabolize fatty acids, which causes cell-autonomous lipid storage in
aging liver and thus contributes to fatty liver (steatosis), a common
and pathologically signiﬁcant complication of liver aging (Ogrodnik et
al. unpublished). Adipocyte senescence is an essential driver of adipose
tissue dysfunction and obesity (Stout et al., 2017), and this link is very
12 V.I. Korolchuk et al. / EBioMedicine 21 (2017) 7–13probably mediated by SAMD. Analysing mitochondrial dysfunction in
aging tissues at single-cell resolution in combinationwith interventions
that selectively ablate senescent cells (senolytics) will enable a better
understanding of the importance of SAMD in aging.
SAMD appears to be a central mediator for interventions that extend
healthy lifespan. Dietary restriction induces autophagy, improves mito-
chondrial function, speciﬁcally in complex I (Miwa et al., 2014) and re-
duces frequencies of senescent cells inmany tissues (Wang et al., 2010).
Similarly the dietary restriction mimetic rapamycin, which also pro-
longs healthy lifespan in many species by activating autophagy
(Kennedy and Lamming, 2016) and improving mitochondrial complex
I function (Miwa et al., 2014), acts as a senostatic, i.e. it inhibits multiple
aspects of the senescent phenotype including SAMD (Demidenko and
Blagosklonny, 2008; Correia-Melo et al., 2016). Recently, metformin
gained increasing attention as a drug that can enhance lifespan and
healthspan not only in rodents but also in man (Bannister et al.,
2014). Metformin improves mitochondrial complex I function (Foretz
et al., 2014), inhibits mTORC1 signalling by activating AMPK (Howell
et al., 2016) and blocks pro-inﬂammatory NF-κB signalling (Saisho,
2015).Whilemetforminmay sensitize some cell types to stress-induced
senescence in vitro, it inhibits the SASP, thus blocking senescent cell-in-
duced bystander effects (Moiseeva et al., 2013) and may act as a
senostatic drug in vivo similar to rapamycin.
Senescent cells typically upregulate anti-apoptotic pathways, and
are preferentially susceptible to inhibition of these pro-survival mecha-
nisms. This has been dubbed the ‘Achilles heel’ of senescent cells and
used as a rationale for the development of senostatic drugs (Kirkland
& Tchkonia, in this volume). It is tempting to speculate that the lowmi-
tochondrial membrane potential found in many senescent cells lies at
the heart of this preferential sensitivity by easing the release of apopto-
sis-stimulating factors from mitochondria. Interestingly in this respect,
a recent screen of compounds that modify autophagy (and possibly
mitophagy) identiﬁed a large number of these as potential senolytics
(Fuhrmann-Stroissig et al., unpublished). It seems probable that for
drugs to effectively extend such a multifaceted phenotype as healthy
lifespan they need to target not just a singular molecular node but a
complex network of aging-determining pathways and mechanisms
like the one deﬁned by the interactions between mitophagy, SAMD
and SASP in cell senescence (see Fig. 3). We believe that improved un-
derstanding of this networkwill offer an exciting avenue in thedevelop-
ment of novel interventions that can prolong healthy lifespan including
senolytic and senostatic agents.
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